Literature DB >> 23941005

Primary uterine cervical cancer: correlation of preoperative magnetic resonance imaging and clinical staging (FIGO) with histopathology findings.

Zdenko Kraljević1, Klaudija Visković, Mario Ledinsky, Dijana Zadravec, Ivan Grbavac, Marijana Bilandzija, Hrvojka Soljacić-Vranes, Krunoslav Kuna, Ksenija Klasnić, Ivan Krolo.   

Abstract

The most commonly used staging system for cervical cancer is based on the International Federation of Gynaecology and Obstetrics (FIGO) staging system. Magnetic resonance imaging (MRI) has been accepted as the optimal tool for evaluation of the main prognostic factors and selection of therapeutic strategy. The purpose of this study was to compare the preoperative clinical examination FIGO staging findings with MRI and postoperative pathology report in females with primary cancer of the cervix. The study prospectively included 46 females consecutively hospitalized at the Department of Gynaecology and Obstetrics at the "Sestre milosrdnice" University Hospital Center in Zagreb. Interviews, clinical examination, transvaginal ultrasound and MRI were performed in all patients. In selected patients the surgical procedure was done and the correlation of clinical findings according to FIGO classifications, MRI and histopathological findings was completed. According to FIGO classification, positive clinical findings for stage IIA were found in 26/46 (55.5%) and stage IIB in 20/46 (44.5%)patients. FIGO MR modified classification confirmed stage IIA in 30/46 (66.6%) and stage IIB in 16/46 (33.4%) patients. Surgery (Wertheim radical hysterectomy with bilateral pelvic and selective para-aortic lymphadenectomy) was performed in 33/46 (71%) patients with clinically, MR, cytologically and pathohistologically confirmed findings of cervical cancer: 26 patients with IIA clinically FIGO stage and 7 with IIB stage. MRI examination proved better than clinical examination in staging of cervical carcinoma with 90.9% versus 79.0% accuracy rate. We suggest the application of the following MR protocol in all clinically staged FIGO IIA and IIB patients: T1W, T2WI and postcontrast dynamic T1WI after 3 and 60 seconds and after 5 minutes, performed on 1.5T MR machine.

Entities:  

Mesh:

Year:  2013        PMID: 23941005

Source DB:  PubMed          Journal:  Coll Antropol        ISSN: 0350-6134


  9 in total

Review 1.  Magnetic resonance imaging for detection of parametrial invasion in cervical cancer: An updated systematic review and meta-analysis of the literature between 2012 and 2016.

Authors:  Sungmin Woo; Chong Hyun Suh; Sang Youn Kim; Jeong Yeon Cho; Seung Hyup Kim
Journal:  Eur Radiol       Date:  2017-07-19       Impact factor: 5.315

Review 2.  Primary vaginal cancer: role of MRI in diagnosis, staging and treatment.

Authors:  C S Gardner; J Sunil; A H Klopp; C E Devine; T Sagebiel; C Viswanathan; P R Bhosale
Journal:  Br J Radiol       Date:  2015-05-12       Impact factor: 3.039

3.  Volume Delineation in Cervical Cancer With T2 and Diffusion-weighted MRI: Agreement on Volumes Between Observers.

Authors:  Consuelo Rosa; Andrea Delli Pizzi; Antonietta Augurio; Luciana Caravatta; Monica DI Tommaso; Erica Mincuzzi; Sebastiano Cinalli; Raffaella Basilico; Annamaria Porreca; Marta DI Nicola; Domenico Genovesi
Journal:  In Vivo       Date:  2020 Jul-Aug       Impact factor: 2.155

4.  The involvement of E6, p53, p16, MDM2 and Gal-3 in the clinical outcome of patients with cervical cancer.

Authors:  Annika Stiasny; Christoph P Freier; Christina Kuhn; Sandra Schulze; Doris Mayr; Christoph Alexiou; Christina Janko; Irmi Wiest; Christian Dannecker; Udo Jeschke; Bernd P Kost
Journal:  Oncol Lett       Date:  2017-08-14       Impact factor: 2.967

Review 5.  The value of advanced MRI techniques in the assessment of cervical cancer: a review.

Authors:  Evelyn Dappa; Tania Elger; Annette Hasenburg; Christoph Düber; Marco J Battista; Andreas M Hötker
Journal:  Insights Imaging       Date:  2017-08-21

6.  Late Radiation-Related Toxicities in Patients Treated for Early-Stage Cervical Carcinoma by Surgery and Adjuvant Radiotherapy: A Retrospective Imaging Study.

Authors:  Katarina Nadova; Miroslava Burghardtova; Klara Fejfarova; Klaudia Reginacova; Hana Malikova
Journal:  Pathol Oncol Res       Date:  2021-09-28       Impact factor: 3.201

7.  From prospective biobanking to precision medicine: BIO-RAIDs - an EU study protocol in cervical cancer.

Authors:  Charlotte Ngo; Sanne Samuels; Ksenia Bagrintseva; Andrea Slocker; Philippe Hupé; Gemma Kenter; Marina Popovic; Nina Samet; Patricia Tresca; Heiko von der Leyen; Eric Deutsch; Roman Rouzier; Lisa Belin; Maud Kamal; Suzy Scholl
Journal:  BMC Cancer       Date:  2015-11-04       Impact factor: 4.430

Review 8.  The Complementary Role of Imaging and Tumor Biomarkerszzm321990in Gynecological Cancers: An Update of the Literature

Authors:  Emanuela Anastasi; Silvia Gigli; Laura Ballesio; Antonio Angeloni; Lucia Manganaro
Journal:  Asian Pac J Cancer Prev       Date:  2018-02-26

9.  Role of ADC values in assessing clinical response and identifying residual disease post-chemo radiation in uterine cervix cancer.

Authors:  Ankush Jajodia; Vivek Mahawar; Arvind K Chaturvedi; Avinash Rao; Rishu Singla; Swarupa Mitra; Sumit Goyal; Sikha Kesan; Sunil Pasricha; Udip Maheshwari; Rupal Tripathi; Venkata Pradeep Babu Koyyala
Journal:  Indian J Radiol Imaging       Date:  2019-12-31
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.